Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	44.61B
Revenue (ttm)	2.52B
Net Income (ttm)	1.47B
Shares Out	301.43M
EPS (ttm)	4.87
PE Ratio	30.40
Forward PE	27.71
Dividend	2.40 (1.62%)
Ex-Dividend Date	Sep 26, 2025

Volume	2,913,177
Average Volume	3,856,719
Open	159.00
Previous Close	150.84
Day's Range	147.84 - 159.00
52-Week Range	147.84 - 237.04
Beta	1.18
RSI	30.68
Earnings Date	Oct 29, 2025

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,223
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2024, SHE:300896's revenue was 3.03 billion, an increase of 5.45% compared to the previous year's 2.87 billion. Earnings were 1.96 billion, an increase of 5.33%.